|
2025
|
Invention
|
Method for preparing zavegepant intermediate and derivative thereof. The present invention relate... |
|
|
Invention
|
Phenylalanine ammonia lyase mutant and use thereof. A phenylalanine ammonia lyase mutant. The mut... |
|
|
Invention
|
Microneedle patch and preparation method therefor. The present invention relates to a microneedle... |
|
|
Invention
|
Synthesis process for upadacitinib or hydrate thereof. Provided is a synthesis process for Upadac... |
|
2024
|
Invention
|
Tyk2 inhibitor and preparation method for intermediates thereof. The present invention provides a... |
|
|
Invention
|
Chemokine receptor modulator preparation method and use. The present invention relates to the fie... |
|
|
Invention
|
Preparation method for pregabalin intermediate. The present invention relates to a synthesis meth... |
|
|
Invention
|
Preparation method for deuterated propargylamine hydrochloride, intermediate thereof, and use. Th... |
|
|
Invention
|
Preparation method for cbl-b regulator, and use. The present invention provides a novel small mol... |
|
|
Invention
|
Preparation method, intermediate and use of finerenone. The present invention relates to a repara... |
|
|
Invention
|
Levodopa-benserazide hydrochloride composition and preparation therefor. Provided in the present ... |
|
|
Invention
|
Preparation method for pyrrolotriazine compound. The present invention relates to the technical f... |
|
|
Invention
|
Method for continuously preparing deuremidevir hydrobromide. A method for preparing deuremidevir ... |
|
|
Invention
|
Chemokine receptor modulator preparation method and use. Provided are a compound and composition ... |
|
|
Invention
|
Composition, and preparation method therefor and use thereof. A composition, and a preparation me... |
|
|
Invention
|
Preparation method for aryl methoxy isoindoline derivative. The present invention relates to a pr... |
|
|
Invention
|
Preparation method of pyrrolotriazine compound. The present invention belongs to the field of dru... |
|
|
Invention
|
Nucleoside analogue targeting telomerase and use thereof. Provided in the present invention are a... |
|
|
Invention
|
Nucleoside analogue and use thereof. Provided in the present invention are a nucleoside analogue ... |
|
|
Invention
|
Salt of dipeptide compound, preparation method therefor, and use thereof. The invention relates t... |
|
|
Invention
|
Pyridazine compound, and preparation method therefor and use thereof. Provided are a pyridazine c... |
|
2023
|
Invention
|
Method for splitting ramipril intermediate. Disclosed is a method for splitting a ramipril interm... |
|
|
Invention
|
Method for preparing lacidipine intermediate. A method for preparing a lacidipine intermediate co... |
|
|
Invention
|
Method for preparing oseltamivir intermediate. Provided in the present invention is a method for ... |
|
|
Invention
|
Preparation method for edoxaban and intermediate thereof. The present invention provides a prepar... |
|
|
Invention
|
Pyrazinamide compound, pharmaceutical composition thereof, and uses thereof as tyk2 inhibitor. Th... |
|
|
Invention
|
Pharmaceutical composition for treating parkinson's disease and preparation method therefor. Prov... |
|
|
Invention
|
Pyridazine compound, and preparation method therefor and use thereof. Provided in the present inv... |
|
|
Invention
|
Method for preparing glucopyranosyl-containing compound.
The present invention relates to a meth... |
|
|
Invention
|
Method for preparing glucopyranosyl-containing compound. The present invention relates to a metho... |
|
|
Invention
|
Method for preparing molnupiravir and intermediate thereof. A method for preparing molnupiravir, ... |
|
2022
|
Invention
|
Plpro inhibitors.
Provided herein are novel compounds (e.g., Formula X or Y), pharmaceutical com... |
|
|
Invention
|
High-purity losartan potassium and preparation method therefor.
The present invention belongs to... |
|
|
Invention
|
Method for preparing high-purity losartan.
Disclosed in the present invention is a method for pr... |
|
|
Invention
|
High-purity losartan potassium and preparation method therefor. The present invention belongs to ... |
|
|
Invention
|
Method for preparing high-purity losartan. Disclosed in the present invention is a method for pre... |
|
|
Invention
|
Biphenyltetrazole compound and preparation method therefor. Provided is a compound. The compound ... |
|
|
Invention
|
Preparation method for drug intermediate. The present invention relates to a preparation method f... |
|
|
Invention
|
Method for synthesizing rivaroxaban.
Provided in the present invention is a method for synthesiz... |
|
|
Invention
|
Method for synthesizing rivaroxaban. 166 alkyl; and X in formula II is bromine or chlorine. The m... |
|
|
Invention
|
Method for preparing lemborexant and method for preparing lemborexant intermediate. Provided in t... |
|
|
Invention
|
Method for preparing lemborexant and method for preparing lemborexant intermediate compound. Prov... |
|
|
Invention
|
Method for purifying levetiracetam intermediate.
The present invention relates to the field of p... |
|
|
Invention
|
Method for purifying levetiracetam intermediate. The present invention relates to the field of ph... |
|
|
Invention
|
Method for purifying pregabalin. The present invention relates to a method for purifying pregabal... |
|
|
Invention
|
Purification method for citalopram or s-citalopram.
The present invention provides a purificatio... |
|
2021
|
Invention
|
Method for purifying key intermediates of citalopram.
The present invention relates to a method ... |
|
|
Invention
|
Lyophilized vortioxetine pamoate powder for injection and preparation method therefor.
Provided ... |
|
|
Invention
|
Bruton's tyrosine kinase inhibitor and preparation method therefor.
A type of Bruton's tyrosine ... |
|
2020
|
Invention
|
Method for preparing brivaracetam and intermediate thereof.
Disclosed is a method for preparing ... |
|
2019
|
P/S
|
Aqueous solutions for medical purposes; medicinal ointments;
crude drug; Chinese medicine nostru... |
|
2013
|
P/S
|
pharmaceutical intermediates for use in the manufacturing of pharmaceuticals medicines for human ... |
|
|
P/S
|
pharmaceutical intermediates for use in the manufacturing of pharmaceuticals |
